Concepedia

Robert Deuson

RD

Statistics

Publications

22

Citations

2K

H-Index

18

Active since

1990

Affiliations

Amgen (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Centers for Disease Control and Prevention

National Center for Immunization and Respiratory Diseases

Ospedale "Santa Maria delle Croci" di Ravenna

Robert Deuson is an author at Amgen (United States) specializing in medicine, chemotherapy, and adverse effects of chemotherapy.

Publications per year

1990–2013

22

Publications

22

Delayed Nausea and Vomiting Continue to Reduce Patients' Quality of Life After Highly and Moderately Emetogenic Chemotherapy Despite Antiemetic Treatment

Brigitte Bloechl‐Daum, Robert Deuson, Panagiotis Mavros et al. · Journal of Clinical Oncology · 2006 · 505 citations

Medicine, Oncology, Pharmacology +17

Incidence of chemotherapy‐induced nausea and emesis after modern antiemetics

Steven M. Grunberg, Robert Deuson, Panagiotis Mavros et al. · Cancer · 2004 · 470 citations · Full text

Nursing, Oncology, Oncology Nursing +15

The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers

Angela Ihbe‐Heffinger, B. Ehlken, R Bernard et al. · Annals of Oncology · 2004 · 144 citations · Full text

Medicine, Oncology, Pharmacoeconomics +16

The impact of chemotherapy-induced nausea and vomiting on health-related quality of life

Enzo Ballatori, Fausto Roila, Benedetta Ruggeri et al. · Supportive Care in Cancer · 2006 · 140 citations

Medicine, Oncology, Pharmacotherapy +14

Chemotherapy-induced nausea and vomiting in routine practice: a European perspective

Agnès Glaus, Cornelia Knipping, Rudolf Morant et al. · Supportive Care in Cancer · 2004 · 104 citations

Medicine, Oncology, Pharmacotherapy +16

1–5 of 22